GSK Investigational Site

Wentworth, KwaZulu-Natal 4052

0 studies enrolling now · 2 studies all time

What they study most

HIV Infections, Human Immunodeficiency Virus Type 1 (HIV-1)

Studies at this site

• Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study — Completed
• A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults — Stopped early